文献速递骨质疏松与钙磷/甲状旁腺

甲状旁腺切除术对原发性甲状旁腺功能亢进症患者骨骼的影响:系统评价与Meta分析

Skeletal Effect of Parathyroidectomy on Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该系统评价与Meta分析比较了原发性甲状旁腺功能亢进症患者接受甲状旁腺切除术与观察的骨折风险和骨密度变化,纳入35项研究共238 188例患者。甲状旁腺切除术显著降低任何部位骨折风险(RR 0.80,95%CI 0.74-0.86)和髋部骨折风险(RR 0.63,95%CI 0.52-0.76),前臂和椎体骨折未见减少;各部位骨密度年变化率在手术组更高。

要点

  • 甲状旁腺切除术显著降低原发性甲状旁腺功能亢进症患者任何部位骨折风险(RR 0.80,95%CI 0.74-0.86)。
  • 髋部骨折风险显著降低(RR 0.63,95%CI 0.52-0.76),前臂和椎体骨折未见减少。
  • 手术组股骨颈、髋部、桡骨和脊柱骨密度年变化率均高于观察组。

核心结论

  • 甲状旁腺切除术显著降低原发性甲状旁腺功能亢进症患者总体骨折和髋部骨折风险,尽管骨密度增幅较小,骨折风险的大幅下降提示甲状旁腺切除术的获益超出矿物质含量提升。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library截至2022年9月,纳入随机对照试验和队列研究,最终纳入35项研究(5项随机对照试验,30项队列研究)的48篇合格文献。
  • 共纳入238 188例原发性甲状旁腺功能亢进症患者,其中甲状旁腺切除术组73 778例,观察组164 410例。
  • 数据提取由2名独立评价者按照PRISMA指南进行。

主要发现

  • 在238 188例患者中,甲状旁腺切除术组较观察组显著降低任何部位骨折风险(RR 0.80,95%CI 0.74-0.86)。
  • 在237 217例患者中,甲状旁腺切除术组较观察组显著降低髋部骨折风险(RR 0.63,95%CI 0.52-0.76)。
  • 在3574例和3795例患者中,前臂骨折和椎体骨折风险未见减少。
  • 甲状旁腺切除术组骨密度年变化率高于观察组:股骨颈1.91%(95%CI 1.14-2.68),髋部1.75%(95%CI 0.58-2.92),桡骨1.75%(95%CI 0.31-3.18),脊柱2.13%(95%CI 1.16-3.10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Parathyroidectomy (PTX) is recommended for curing primary hyperparathyroidism (PHPT), although uncertainty remains regarding the extent of fracture risk reduction following surgery. OBJECTIVE: This work aimed to compare fracture risk and bone mineral density (BMD) changes in patients with PHPT undergoing PTX vs observation (OBS). METHODS: We systematically searched PubMed, Embase, and the Cochrane Library until September 2022, including randomized controlled trials (RCTs) and cohort studies, and reviewed citations from previous reviews. Among 1260 initial records, 48 eligible articles from 35 studies (5 RCTs; 30 cohorts) included PHPT patients receiving PTX or OBS interventions with reported fracture events at any site, including the hip, spine, or forearm, and/or BMD changes at each location. Data extraction followed Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines by 2 independent reviewers. RESULTS: In 238 188 PHPT patients (PTX: 73 778 vs OBS: 164 410), PTX significantly reduced fractures at any site (relative risk [RR], 0.80; 95% CI, 0.74-0.86) compared to OBS. In 237 217 patients (PTX: 73 458 vs OBS: 163 759), the risk of hip fractures decreased (RR, 0.63; 95% CI, 0.52-0.76). No reduction in forearm and vertebral fractures was observed in 3574 and 3795 patients, respectively. The annual percentage BMD changes from baseline were higher in the PTX group: femoral neck, 1.91% (95% CI, 1.14-2.68); hip, 1.75% (95% CI, 0.58-2.92); radius, 1.75% (95% CI, 0.31-3.18); spine, 2.13% (95% CI, 1.16-3.10). CONCLUSION: PTX significantly reduced overall and hip fracture risks in PHPT patients. Despite minimal BMD increase, the substantial decrease in fracture risk suggests additional benefits of PTX beyond mineral content enhancement.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kongsaree N, Thanyajaroen T, Dechates B, et al. Skeletal Effect of Parathyroidectomy on Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2024. PMID: 38739762. doi:10.1210/clinem/dgae326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。